CCCC icon

C4 Therapeutics
CCCC

Overview Fund Activity

117 hedge funds and large institutions have $229M invested in C4 Therapeutics in 2022 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 42 increasing their positions, 33 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
117
Holders Change
+3
Holders Change %
+2.63%
% of All Funds
1.89%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
17
Increased
42
Reduced
33
Closed
13
Calls
$200K
Puts
$21K
Net Calls
+$179K
Net Calls Change
-$42K

Top Buyers

1
SCM
Soleus Capital Management
Connecticut
$14.4M
2
ACH
ArrowMark Colorado Holdings
Colorado
$34.2M
3
State Street
State Street
Massachusetts
$14.4M
4
Citadel Advisors
Citadel Advisors
Florida
$2.24M
5
AQR Capital Management
AQR Capital Management
Connecticut
$1.62M

Top Sellers

1
PAMS
Pictet Asset Management (Switzerland)
Switzerland
$0
2
PA
Perceptive Advisors
New York
$0
3
Janus Henderson Group
Janus Henderson Group
United Kingdom
$4.36M
4
T. Rowe Price Investment Management
T. Rowe Price Investment Management
Maryland
$0
5
DCM
Driehaus Capital Management
Illinois
$2.04M
Name Holding Trade Value Shares
Change 		Shares
Change %
BMSSC
126
B. Metzler seel. Sohn & Co
Germany
– -$129K -14,700 Closed
Ensign Peak Advisors
127
Ensign Peak Advisors
Utah
– -$63K -7,230 Closed
Wells Fargo
128
Wells Fargo
California
– -$54K -6,209 Closed
2 3 4 5
6